pyrrolidine dithiocarbamate has been researched along with 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, J; Choi, M; Han, SB; Hwang, YS; Jeong, Y; Jo, H; Jung, JK; Kim, Y; Kumar, AS; Lee, H; Lee, J; Oh, Y; Yun, J | 1 |
Cho, J; Choi, M; Han, SB; Jo, H; Jung, JK; Kim, Y; Kwak, JH; Lee, H; Lee, J; Lee, K; Park, HJ; Sateesh Kumar, A; Yun, J | 1 |
Cho, J; Choi, M; Han, SB; Jo, H; Jung, JK; Jung, Y; Kang, JS; Kim, S; Kim, Y; Kumar, AS; Kwak, JH; Lee, H; Lee, K; Yun, J | 1 |
3 other study(ies) available for pyrrolidine dithiocarbamate and 6-hydroxy-7-methoxychroman-2-carboxylic acid phenylamide
Article | Year |
---|---|
Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors.
Topics: Anilides; Antineoplastic Agents; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; NF-kappa B; Structure-Activity Relationship | 2014 |
Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Topics: Amides; Animals; Antineoplastic Agents; Benzofurans; Carboxylic Acids; Cell Line; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Humans; Lipopolysaccharides; Mice; NF-kappa B; Protein Binding; Signal Transduction; Structure-Activity Relationship | 2015 |
Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents.
Topics: | 2016 |